Skip to main content
main-content

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

Erschienen in: European Surgery 6/2019

24.10.2019 | original article

Psycho-oncological distress in patients with peritoneal surface malignancies treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

verfasst von: M.D. Andreas Brandl, M.D. Shadi Katou, Antonia Pallauf, M.D. Ph.D. Johann Pratschke, M.D., Ph.D. Beate Rau, Ph.D. Ute Goerling

Erschienen in: European Surgery | Ausgabe 6/2019

Einloggen, um Zugang zu erhalten
share
TEILEN

Summary

Background

Patients with peritoneal metastases suffer from physical and psychological distress. The aim of our investigation was to identify highly distressed patients, collect demographic data, and examine correlations between distress score and clinical outcome.

Methods

This retrospective analysis included all patients who were treated for peritoneal surface malignancies with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in our department. Psycho-oncological screening was conducted preoperatively.

Results

From a total of 213 patients, 105 (49.3%) participated in the psycho-oncological screening. Women had a higher score (6.2 ± 2.6) compared to men (4.8 ± 3.4; p = 0.02). Age (p = 0.15) and Peritoneal Cancer Index (p = 0.90) had no significant influence on the score. The postoperative rate for surgical (19/73) or non-surgical complications (20/73) in highly distressed patients was comparable to patients with low distress (9/31, 11/31; p = 0.46, p = 0.28). Psychological problems due to sadness (Odds Ratio [OR] 2.69; p = 0.009), sleeplessness (OR 3.01; p = 0.004), and the physical ability to get around (OR 2.65; p = 0.01) were identified as having the greatest impact on distress scores.

Conclusion

The mean distress score in patients with peritoneal surface malignancies is high (5.4 ± 2.7), is not related to the medical prognosis of the patients due to their underlying disease, and showed no correlation to the complication rate. Sadness and problems with sleep and getting around have a major influence on this score.
Literatur
1.
Zurück zum Zitat Klaver CE, Groenen H, Morton DG, Laurberg S, Bemelman WA, Tanis PJ, et al. Recommendations and consensus on the treatment of peritoneal metastases of colorectal origin: a systematic review of national and international guidelines. Colorectal Dis. 2017;19(3):224–36. CrossRef Klaver CE, Groenen H, Morton DG, Laurberg S, Bemelman WA, Tanis PJ, et al. Recommendations and consensus on the treatment of peritoneal metastases of colorectal origin: a systematic review of national and international guidelines. Colorectal Dis. 2017;19(3):224–36. CrossRef
2.
Zurück zum Zitat Brandl A, Pratschke J, Rau B. Chirurgisch-onkologische Therapie primärer und sekundärer peritonealer Neoplasien. Eur Surg. 2018;50(6):229–312. CrossRef Brandl A, Pratschke J, Rau B. Chirurgisch-onkologische Therapie primärer und sekundärer peritonealer Neoplasien. Eur Surg. 2018;50(6):229–312. CrossRef
3.
Zurück zum Zitat Chua TC, Moran BJ, Sugarbaker PH, Levine EA, Glehen O, Gilly FN, et al. Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol. 2012;30(20):2449–56. CrossRef Chua TC, Moran BJ, Sugarbaker PH, Levine EA, Glehen O, Gilly FN, et al. Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol. 2012;30(20):2449–56. CrossRef
4.
Zurück zum Zitat Elias D, Gilly F, Quenet F, Bereder JM, Sideris L, Mansvelt B, et al. Pseudomyxoma peritonei: a French multicentric study of 301 patients treated with cytoreductive surgery and intraperitoneal chemotherapy. Eur J Surg Oncol. 2010;36(5):456–62. CrossRef Elias D, Gilly F, Quenet F, Bereder JM, Sideris L, Mansvelt B, et al. Pseudomyxoma peritonei: a French multicentric study of 301 patients treated with cytoreductive surgery and intraperitoneal chemotherapy. Eur J Surg Oncol. 2010;36(5):456–62. CrossRef
5.
Zurück zum Zitat Faron M, Macovei R, Goere D, Honore C, Benhaim L, Elias D. Linear relationship of peritoneal cancer index and survival in patients with peritoneal metastases from colorectal cancer. Ann Surg Oncol. 2016;23(1):114–9. CrossRef Faron M, Macovei R, Goere D, Honore C, Benhaim L, Elias D. Linear relationship of peritoneal cancer index and survival in patients with peritoneal metastases from colorectal cancer. Ann Surg Oncol. 2016;23(1):114–9. CrossRef
6.
Zurück zum Zitat Verwaal VJ, van Ruth S, de Bree E, van Sloothen GW, van Tinteren H, Boot H, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol. 2003;21(20):3737–43. CrossRef Verwaal VJ, van Ruth S, de Bree E, van Sloothen GW, van Tinteren H, Boot H, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol. 2003;21(20):3737–43. CrossRef
7.
Zurück zum Zitat Glehen O, Gilly FN, Arvieux C, Cotte E, Boutitie F, Mansvelt B, et al. Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy. Ann Surg Oncol. 2010;17(9):2370–7. CrossRef Glehen O, Gilly FN, Arvieux C, Cotte E, Boutitie F, Mansvelt B, et al. Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy. Ann Surg Oncol. 2010;17(9):2370–7. CrossRef
9.
Zurück zum Zitat Quenet F, Goere D, Mehta SS, Roca L, Dumont F, Hessissen M, et al. Results of two bi-institutional prospective studies using intraperitoneal oxaliplatin with or without irinotecan during HIPEC after cytoreductive surgery for colorectal carcinomatosis. Ann Surg. 2011;254(2):294–301. CrossRef Quenet F, Goere D, Mehta SS, Roca L, Dumont F, Hessissen M, et al. Results of two bi-institutional prospective studies using intraperitoneal oxaliplatin with or without irinotecan during HIPEC after cytoreductive surgery for colorectal carcinomatosis. Ann Surg. 2011;254(2):294–301. CrossRef
10.
Zurück zum Zitat Singer S, Das-Munshi J, Brahler E. Prevalence of mental health conditions in cancer patients in acute care—a meta-analysis. Ann Oncol. 2010;21(5):925–30. CrossRef Singer S, Das-Munshi J, Brahler E. Prevalence of mental health conditions in cancer patients in acute care—a meta-analysis. Ann Oncol. 2010;21(5):925–30. CrossRef
11.
Zurück zum Zitat Cohen L, Fouladi RT, Katz J. Preoperative coping strategies and distress predict postoperative pain and morphine consumption in women undergoing abdominal gynecologic surgery. J Psychosom Res. 2005;58(2):201–9. CrossRef Cohen L, Fouladi RT, Katz J. Preoperative coping strategies and distress predict postoperative pain and morphine consumption in women undergoing abdominal gynecologic surgery. J Psychosom Res. 2005;58(2):201–9. CrossRef
12.
Zurück zum Zitat Badger TA, Braden CJ, Mishel MH. Depression burden, self-help interventions, and side effect experience in women receiving treatment for breast cancer. Oncol Nurs Forum. 2001;28(3):567–74. PubMed Badger TA, Braden CJ, Mishel MH. Depression burden, self-help interventions, and side effect experience in women receiving treatment for breast cancer. Oncol Nurs Forum. 2001;28(3):567–74. PubMed
13.
Zurück zum Zitat Gilbar O, De-Nour AK. Adjustment to illness and dropout of chemotherapy. J Psychosom Res. 1989;33(1):1–5. CrossRef Gilbar O, De-Nour AK. Adjustment to illness and dropout of chemotherapy. J Psychosom Res. 1989;33(1):1–5. CrossRef
14.
Zurück zum Zitat Spiegel D. Mind matters in cancer survival. Psychooncology. 2012;21(6):588–93. CrossRef Spiegel D. Mind matters in cancer survival. Psychooncology. 2012;21(6):588–93. CrossRef
15.
Zurück zum Zitat Pirl WF, Greer JA, Traeger L, Jackson V, Lennes IT, Gallagher ER, et al. Depression and survival in metastatic non-small-cell lung cancer: effects of early palliative care. J Clin Oncol. 2012;30(12):1310–5. CrossRef Pirl WF, Greer JA, Traeger L, Jackson V, Lennes IT, Gallagher ER, et al. Depression and survival in metastatic non-small-cell lung cancer: effects of early palliative care. J Clin Oncol. 2012;30(12):1310–5. CrossRef
16.
Zurück zum Zitat Mitchell AJ. Pooled results from 38 analyses of the accuracy of distress thermometer and other ultra-short methods of detecting cancer-related mood disorders. J Clin Oncol. 2007;25(29):4670–81. CrossRef Mitchell AJ. Pooled results from 38 analyses of the accuracy of distress thermometer and other ultra-short methods of detecting cancer-related mood disorders. J Clin Oncol. 2007;25(29):4670–81. CrossRef
17.
Zurück zum Zitat Roth AJ, Kornblith AB, Batel-Copel L, Peabody E, Scher HI, Holland JC. Rapid screening for psychologic distress in men with prostate carcinoma: a pilot study. Cancer. 1998;82(10):1904–8. CrossRef Roth AJ, Kornblith AB, Batel-Copel L, Peabody E, Scher HI, Holland JC. Rapid screening for psychologic distress in men with prostate carcinoma: a pilot study. Cancer. 1998;82(10):1904–8. CrossRef
18.
Zurück zum Zitat Hegel MT, Collins ED, Kearing S, Gillock KL, Moore CP, Ahles TA. Sensitivity and specificity of the Distress Thermometer for depression in newly diagnosed breast cancer patients. Psychooncology. 2008;17(6):556–60. CrossRef Hegel MT, Collins ED, Kearing S, Gillock KL, Moore CP, Ahles TA. Sensitivity and specificity of the Distress Thermometer for depression in newly diagnosed breast cancer patients. Psychooncology. 2008;17(6):556–60. CrossRef
19.
Zurück zum Zitat Carlson LE, Waller A, Mitchell AJ. Screening for distress and unmet needs in patients with cancer: review and recommendations. J Clin Oncol. 2012;30(11):1160–77. CrossRef Carlson LE, Waller A, Mitchell AJ. Screening for distress and unmet needs in patients with cancer: review and recommendations. J Clin Oncol. 2012;30(11):1160–77. CrossRef
20.
Zurück zum Zitat Mehnert A, Müller D, Lehmann C, Koch U. Die deutsche Version des NCCN Distress-Thermometers. Z Psychiatr Psychol Psychother. 2006;54:213–23. Mehnert A, Müller D, Lehmann C, Koch U. Die deutsche Version des NCCN Distress-Thermometers. Z Psychiatr Psychol Psychother. 2006;54:213–23.
21.
Zurück zum Zitat Chiou YJ, Chiu NM, Wang LJ, Li SH, Lee CY, Wu MK, et al. Prevalence and related factors of psychological distress among cancer inpatients using routine Distress Thermometer and Chinese Health Questionnaire screening. Neuropsychiatr Dis Treat. 2016;12:2765–73. CrossRef Chiou YJ, Chiu NM, Wang LJ, Li SH, Lee CY, Wu MK, et al. Prevalence and related factors of psychological distress among cancer inpatients using routine Distress Thermometer and Chinese Health Questionnaire screening. Neuropsychiatr Dis Treat. 2016;12:2765–73. CrossRef
22.
Zurück zum Zitat Lavelle C, Ismail MF, Doherty K, Bowler A, Mohammad MM, Cassidy EM. Association between psychological distress and cancer type in patients referred to a psycho-oncology service. Ir Med J. 2017;110(6):579. PubMed Lavelle C, Ismail MF, Doherty K, Bowler A, Mohammad MM, Cassidy EM. Association between psychological distress and cancer type in patients referred to a psycho-oncology service. Ir Med J. 2017;110(6):579. PubMed
23.
Zurück zum Zitat Aass N, Fossa SD, Dahl AA, Moe TJ. Prevalence of anxiety and depression in cancer patients seen at the Norwegian Radium Hospital. Eur J Cancer. 1997;33(10):1597–604. CrossRef Aass N, Fossa SD, Dahl AA, Moe TJ. Prevalence of anxiety and depression in cancer patients seen at the Norwegian Radium Hospital. Eur J Cancer. 1997;33(10):1597–604. CrossRef
24.
Zurück zum Zitat Dolbeault S, Bredart A, Mignot V, Hardy P, Gauvain-Piquard A, Mandereau L, et al. Screening for psychological distress in two French cancer centers: feasibility and performance of the adapted distress thermometer. Palliat Support Care. 2008;6(2):107–17. CrossRef Dolbeault S, Bredart A, Mignot V, Hardy P, Gauvain-Piquard A, Mandereau L, et al. Screening for psychological distress in two French cancer centers: feasibility and performance of the adapted distress thermometer. Palliat Support Care. 2008;6(2):107–17. CrossRef
25.
Zurück zum Zitat Faller H, Weis J, Koch U, Brahler E, Harter M, Keller M, et al. Utilization of professional psychological care in a large German sample of cancer patients. Psychooncology. 2017;26(4):537–43. CrossRef Faller H, Weis J, Koch U, Brahler E, Harter M, Keller M, et al. Utilization of professional psychological care in a large German sample of cancer patients. Psychooncology. 2017;26(4):537–43. CrossRef
26.
Zurück zum Zitat Fiszer C, Dolbeault S, Sultan S, Bredart A. Prevalence, intensity, and predictors of the supportive care needs of women diagnosed with breast cancer: a systematic review. Psychooncology. 2014;23(4):361–74. CrossRef Fiszer C, Dolbeault S, Sultan S, Bredart A. Prevalence, intensity, and predictors of the supportive care needs of women diagnosed with breast cancer: a systematic review. Psychooncology. 2014;23(4):361–74. CrossRef
27.
Zurück zum Zitat Gessler S, Low J, Daniells E, Williams R, Brough V, Tookman A, et al. Screening for distress in cancer patients: is the distress thermometer a valid measure in the UK and does it measure change over time? A prospective validation study. Psychooncology. 2008;17(6):538–47. CrossRef Gessler S, Low J, Daniells E, Williams R, Brough V, Tookman A, et al. Screening for distress in cancer patients: is the distress thermometer a valid measure in the UK and does it measure change over time? A prospective validation study. Psychooncology. 2008;17(6):538–47. CrossRef
28.
Zurück zum Zitat Feldstain A, Tomei C, Belanger M, Lebel S. Screening for distress in patients with cancer: methodologic considerations. Curr Oncol. 2014;21(2):e330–e3. CrossRef Feldstain A, Tomei C, Belanger M, Lebel S. Screening for distress in patients with cancer: methodologic considerations. Curr Oncol. 2014;21(2):e330–e3. CrossRef
29.
Zurück zum Zitat Philip EJ, Merluzzi TV. Psychosocial issues in post-treatment cancer survivors: desire for support and challenges in identifying individuals in need. J Psychosoc Oncol. 2016;34(3):223–39. CrossRef Philip EJ, Merluzzi TV. Psychosocial issues in post-treatment cancer survivors: desire for support and challenges in identifying individuals in need. J Psychosoc Oncol. 2016;34(3):223–39. CrossRef
30.
Zurück zum Zitat Faller H, Schuler M, Richard M, Heckl U, Weis J, Kuffner R. Effects of psycho-oncologic interventions on emotional distress and quality of life in adult patients with cancer: Systematic review and meta-analysis. J Clin Oncol. 2013;31(6):782–93. CrossRef Faller H, Schuler M, Richard M, Heckl U, Weis J, Kuffner R. Effects of psycho-oncologic interventions on emotional distress and quality of life in adult patients with cancer: Systematic review and meta-analysis. J Clin Oncol. 2013;31(6):782–93. CrossRef
31.
Zurück zum Zitat Goerling U, Foerg A, Sander S, Schramm N, Schlag PM. The impact of short-term psycho-oncological interventions on the psychological outcome of cancer patients of a surgical-oncology department—a randomised controlled study. Eur J Cancer. 2011;47(13):2009–14. CrossRef Goerling U, Foerg A, Sander S, Schramm N, Schlag PM. The impact of short-term psycho-oncological interventions on the psychological outcome of cancer patients of a surgical-oncology department—a randomised controlled study. Eur J Cancer. 2011;47(13):2009–14. CrossRef
32.
Zurück zum Zitat Herrmann C, Buss U. Vorstellung und Validierung einer deutschen Version der “Hospital Anxiety and Depression Scale” (HAD-Skala); ein Fragebogen zur Erfassung des psychischen Befindens bei Patienten mit körperlichen Beschwerden. Diagnostica. 1994;40:143–54. Herrmann C, Buss U. Vorstellung und Validierung einer deutschen Version der “Hospital Anxiety and Depression Scale” (HAD-Skala); ein Fragebogen zur Erfassung des psychischen Befindens bei Patienten mit körperlichen Beschwerden. Diagnostica. 1994;40:143–54.
33.
Zurück zum Zitat Linden W, Girgis A. Psychological treatment outcomes for cancer patients: what do meta-analyses tell us about distress reduction? Psychooncology. 2012;21(4):343–50. CrossRef Linden W, Girgis A. Psychological treatment outcomes for cancer patients: what do meta-analyses tell us about distress reduction? Psychooncology. 2012;21(4):343–50. CrossRef
34.
Zurück zum Zitat Patsou ED, Alexias GD, Anagnostopoulos FG, Karamouzis MV. Effects of physical activity on depressive symptoms during breast cancer survivorship: a meta-analysis of randomised control trials. ESMO Open. 2017;2(5):e271. CrossRef Patsou ED, Alexias GD, Anagnostopoulos FG, Karamouzis MV. Effects of physical activity on depressive symptoms during breast cancer survivorship: a meta-analysis of randomised control trials. ESMO Open. 2017;2(5):e271. CrossRef
35.
Zurück zum Zitat Nicolaisen A, Hagedoorn M, Hansen DG, Flyger HL, Christensen R, Rottmann N, et al. The effect of an attachment-oriented couple intervention for breast cancer patients and partners in the early treatment phase: a randomised controlled trial. Psychooncology. 2017; https://​doi.​org/​10.​1002/​pon.​4613. CrossRef Nicolaisen A, Hagedoorn M, Hansen DG, Flyger HL, Christensen R, Rottmann N, et al. The effect of an attachment-oriented couple intervention for breast cancer patients and partners in the early treatment phase: a randomised controlled trial. Psychooncology. 2017; https://​doi.​org/​10.​1002/​pon.​4613. CrossRef
38.
Zurück zum Zitat Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010;363(8):733–42. CrossRef Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010;363(8):733–42. CrossRef
39.
Zurück zum Zitat Heron-Speirs HA, Harvey ST, Baken DM. Moderators of psycho-oncology therapy effectiveness: meta-analysis of therapy characteristics. J Psychosoc Oncol. 2013;31(6):617–41. CrossRef Heron-Speirs HA, Harvey ST, Baken DM. Moderators of psycho-oncology therapy effectiveness: meta-analysis of therapy characteristics. J Psychosoc Oncol. 2013;31(6):617–41. CrossRef
41.
Zurück zum Zitat Bidstrup PE, Mertz BG, Dalton SO, Deltour I, Kroman N, Kehlet H, et al. Accuracy of the Danish version of the “distress thermometer”. Psychooncology. 2012;21(4):436–43. CrossRef Bidstrup PE, Mertz BG, Dalton SO, Deltour I, Kroman N, Kehlet H, et al. Accuracy of the Danish version of the “distress thermometer”. Psychooncology. 2012;21(4):436–43. CrossRef
42.
Zurück zum Zitat Mejdahl MK, Mertz BG, Bidstrup PE, Andersen KG. Preoperative distress predicts persistent pain after breast cancer treatment: a prospective cohort study. J Natl Compr Canc Netw. 2015;13(8):995–1003. quiz. CrossRef Mejdahl MK, Mertz BG, Bidstrup PE, Andersen KG. Preoperative distress predicts persistent pain after breast cancer treatment: a prospective cohort study. J Natl Compr Canc Netw. 2015;13(8):995–1003. quiz. CrossRef
43.
Zurück zum Zitat Tao WW, Jiang P, Liu Y, Aungsuroch Y, Tao XM. Psycho-oncologic interventions to reduce distress in cancer patients: a meta-analysis of controlled clinical studies published in People’s Republic of China. Psychooncology. 2015;24(3):269–78. CrossRef Tao WW, Jiang P, Liu Y, Aungsuroch Y, Tao XM. Psycho-oncologic interventions to reduce distress in cancer patients: a meta-analysis of controlled clinical studies published in People’s Republic of China. Psychooncology. 2015;24(3):269–78. CrossRef
Metadaten
Titel
Psycho-oncological distress in patients with peritoneal surface malignancies treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
verfasst von
M.D. Andreas Brandl
M.D. Shadi Katou
Antonia Pallauf
M.D. Ph.D. Johann Pratschke
M.D., Ph.D. Beate Rau
Ph.D. Ute Goerling
Publikationsdatum
24.10.2019
Verlag
Springer Vienna
Erschienen in
European Surgery / Ausgabe 6/2019
Print ISSN: 1682-8631
Elektronische ISSN: 1682-4016
DOI
https://doi.org/10.1007/s10353-019-00614-2